| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5890516 | Bone | 2014 | 9 Pages |
Abstract
Denosumab dominated all comparators, including generic bisphosphonates, in the treatment of osteoporosis in men who were â¥Â 75 years old in Sweden.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
A. Parthan, M. Kruse, I. Agodoa, S. Silverman, E. Orwoll,